Olema gives small update to breast cancer drug at center of layoffs, 2021 data leak

Olema Pharmaceuticals is out with more data on its investigational breast cancer drug, for which it shed 25% of its workforce two months ago to keep funding its research. The San Francisco-based biotech said its drug, which was at the center of a “falsified” data leak in November 2021, was…